Literature DB >> 19453313

Influence of promethazine on cardiac repolarisation: a double-blind, midazolam-controlled study.

R Owczuk1, P Twardowski, A Dylczyk-Sommer, M A Wujtewicz, W Sawicka, B Drogoszewska, M Wujtewicz.   

Abstract

Drugs used in anaesthesia may provoke torsadogenic changes in cardiac repolarisation. The aim of this study was to assess the effect of promethazine on the parameters of ventricular repolarisation: QTc interval and transmural dispersion of repolarisation. Forty patients were randomly allocated to receive promethazine (25 mg) or midazolam (2.5 mg). Changes in the ECG and arterial blood pressure were recorded. Correction of QT interval was calculated using Bazett's formula and Fridericia's correction; transmural dispersion of repolarisation was determined as T(peak)-T(end) time. Significant prolongation of QT interval, corrected with both formulae, was detected in patients receiving promethazine, while no change in the QTc value was observed in the midazolam group. There were no significant differences in T(peak)-T(end) time either between or within the groups. In conclusion, promethazine induces significant QTc prolongation but the lack of influence on transmural dispersion of repolarisation makes the risk of its torsadogenic action very low.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19453313     DOI: 10.1111/j.1365-2044.2009.05890.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  8 in total

1.  Promethazine use among chronic pain patients.

Authors:  Kara L Lynch; Brad J Shapiro; Diana Coffa; Scott P Novak; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2015-02-26       Impact factor: 4.492

2.  Clinical guideline: management of gastroparesis.

Authors:  Michael Camilleri; Henry P Parkman; Mehnaz A Shafi; Thomas L Abell; Lauren Gerson
Journal:  Am J Gastroenterol       Date:  2012-11-13       Impact factor: 10.864

3.  Small doses of droperidol do not present relevant torsadogenic actions: a double-blind, ondansetron-controlled study.

Authors:  Krzysztof Tracz; Radosław Owczuk
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

4.  Drugs to be avoided in patients with long QT syndrome: Focus on the anaesthesiological management.

Authors:  Giovanni Fazio; Federica Vernuccio; Giuseppe Grutta; Giuseppe Lo Re
Journal:  World J Cardiol       Date:  2013-04-26

5.  Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action.

Authors:  Nadine Vonderlin; Fathima Fischer; Edgar Zitron; Claudia Seyler; Daniel Scherer; Dierk Thomas; Hugo A Katus; Eberhard P Scholz
Journal:  Drug Des Devel Ther       Date:  2015-02-16       Impact factor: 4.162

6.  Effects of balanced propofol sedation on QT, corrected QT, and P-wave dispersion on upper endoscopy.

Authors:  Esef Bolat; Mehmet Çelikbilek; Savaş Sarıkaya; Yunus Keser Yılmaz; Serkan Doğan; Ömer Özbakır
Journal:  Anatol J Cardiol       Date:  2015-07-03       Impact factor: 1.596

Review 7.  PONV management in patients with QTc prolongation on the EKG.

Authors:  S Soghomonyan; N Stoicea; W Ackermann; S P Bhandary
Journal:  Front Pharmacol       Date:  2021-01-12       Impact factor: 5.810

Review 8.  Gastric electrical stimulation: An emerging therapy for children with intractable gastroparesis.

Authors:  Aniruddh Setya; Priyanka Nair; Sam Xianjun Cheng
Journal:  World J Gastroenterol       Date:  2019-12-28       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.